MSA
Marino Stram & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
396
+20
| +5% | +$10.5K | 0.04% | 171 |
|
|
2025
Q1 | $239K | Hold |
376
| – | – | 0.05% | 150 |
|
|
2024
Q4 | $268K | Buy |
376
+4
| +1% | +$2.85K | 0.06% | 143 |
|
|
2024
Q3 | $391K | Hold |
372
| – | – | 0.09% | 122 |
|
|
2024
Q2 | $391K | Hold |
372
| – | – | 0.1% | 113 |
|
|
2024
Q1 | $358K | Hold |
372
| – | – | 0.08% | 124 |
|
|
2023
Q4 | $327K | Hold |
372
| – | – | 0.08% | 129 |
|
|
2023
Q3 | $306K | Sell |
372
-7
| -2% | -$5.76K | 0.09% | 125 |
|
|
2023
Q2 | $272K | Hold |
379
| – | – | 0.08% | 133 |
|
|
2023
Q1 | $311K | Hold |
379
| – | – | 0.09% | 122 |
|
|
2022
Q4 | $273K | Hold |
379
| – | – | 0.09% | 124 |
|
|
2022
Q3 | $261K | Sell |
379
-45
| -11% | -$31K | 0.09% | 120 |
|
|
2022
Q2 | $251K | Hold |
424
| – | – | 0.09% | 125 |
|
|
2022
Q1 | $296K | Hold |
424
| – | – | 0.09% | 125 |
|
|
2021
Q4 | $268K | Hold |
424
| – | – | 0.08% | 130 |
|
|
2021
Q3 | $257K | Buy |
+424
| New | +$257K | 0.09% | 126 |
|